Scientific Research News

LONDON & CHICAGO--(BUSINESS WIRE)--Anova Enterprises, Inc. (Anova), a technology enabled CRO dedicated to accelerating promising treatments, today announced its partnership with Nouveau Biosciences, Inc. to conduct cancer focused clinical trials for their lead asset Kromastat. Nouveau Biosciences is a biotechnology company pioneering novel targeted nanomedicines to improve cancer therapy. Nouveau Biosciences has developed a proprietary drug discovery technology coupled to a polymer-based nanoch...

SINGAPORE & SAN DIEGO--(BUSINESS WIRE)--GemPharmatech, an international provider of in vivo efficacy testing and genetically engineered animal models, and Humlab Global, a Singapore-based developer of humanized mouse models and translational research solutions, today announced the signing of an agreement for the global distribution of existing and novel humanized strains. The rapid development of advanced therapeutics has increased the need for in vivo models that better predict drug efficacy a...

ALEXANDRIA, Va.--(BUSINESS WIRE)--MPR Associates announces Suzanne P. McKillop, PE, Senior Technical Advisor, begins term as SVP of Standards and Certification for ASME....

DENVER--(BUSINESS WIRE)--Voyager Technologies (NYSE: VOYG) signed a memorandum of understanding (MOU) with The Pennsylvania State University, expanding the Voyager Institute for Space, Technology and Advancement (VISTA) ecosystem. The collaboration will develop joint research programs and applications across in-space research and manufacturing and national security, fusing commercial innovation with defense mission expertise.“This announcement is the latest in a series of strategic initiatives t...

HAYWARD, Calif.--(BUSINESS WIRE)--Aqtual appointed Ferhan Qureshi as Chief Technology Officer and Bill Arteca as Head of Biospecimen Strategy, bolstering its leadership team....

OKLAHOMA CITY--(BUSINESS WIRE)--Cytovance Biologics, a leading US-based contract development and manufacturing organization (CDMO) serving the biopharmaceutical industry, today announced the expansion of its upstream process development offerings with the addition of perfusion capabilities. The new capability provides biopharmaceutical companies with an additional process development option alongside traditional fed-batch manufacturing, enabling Cytovance to better support programs requiring hi...

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced its support for the Minimally Invasive Neurosurgery Trial for Ultra-early Treatment (MINUTE) Trial, a prospective, multicenter, randomized study evaluating whether the SCUBA technique, an endoscopic, catheter-based approach for ultra-early evacuation of basal ganglia intracerebral hemorrhage (BGH), is a promising alternative to standard medical management to pote...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TruTechnologies, a clinical trial software company delivering real-time visibility into trial execution at the point of care, today reveals a new brand identity and updated website. This reimagining of the brand comes as the pharmaceutical industry reaches a critical inflection point. Recent federal initiatives, including the FDA’s real-time clinical trials pilot program and HHS’s Operation TrialBlazer, have put renewed focus on modernizing clinica...

VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced plans to release results for the second quarter of 2026. Press release date / time: Wednesday, August 5 shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time. Conference call date / time: Thursday, August 6, at 15:30 Frankfurt time / 14:30 London time / 09:30 New York time. Three options for joining the conference call Register for call back connection - Click her...

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for second quarter 2026 after market close on Tuesday, July 28, 2026. Following the news release, the company will host a conference call the next day, Wednesday, July 29, 2026, at 10:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be availabl...